Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness and Safety of cNEP in Ethnic Japanese With Obstructive Sleep Apnea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03375905
Recruitment Status : Completed
First Posted : December 18, 2017
Last Update Posted : September 19, 2019
Sponsor:
Information provided by (Responsible Party):
Sommetrics, Inc.

Brief Summary:
The aim of this study is to evaluate the effectiveness and safety of cNEP (continuous negative external pressure) for the treatment of obstructive sleep apnea during two weeks of home use in subjects of Japanese ethnicity.

Condition or disease Intervention/treatment Phase
Obstructive Sleep Apnea Device: cNEP Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pilot Study to Evaluate the Effectiveness and Safety of the aerSleep™ System in an Ethnic Japanese Population Diagnosed With Obstructive Sleep Apnea (OSA)
Actual Study Start Date : December 7, 2017
Actual Primary Completion Date : March 28, 2019
Actual Study Completion Date : April 26, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea

Arm Intervention/treatment
Experimental: cNEP
cNEP treatment
Device: cNEP
subjects with OSA will be treated with the cNEP device with the goal of reducing the number of apneas and hypopneas
Other Name: continuous negative external pressure




Primary Outcome Measures :
  1. proportion of sustained responders [ Time Frame: two weeks after initiation of treatment ]
    reduction of AHI of >50% and to <15/hr from qualifying PSG


Secondary Outcome Measures :
  1. proportion of initial responders [ Time Frame: at PSG 1, one day ]
    reduction of AHI of >50% and to <15/hr from qualifying PSG

  2. AHI comparison with qualifying PSG [ Time Frame: one day, on three separate study occasions ]
    apnea-hypopnea index

  3. ODI comparison with qualifying PSG [ Time Frame: one day, on three separate study occasions ]
    oxygen desaturation index

  4. SpO2 <90% comparison with qualifying PSG [ Time Frame: one day, on three separate study occasions ]
    oxygen desaturation index <90%

  5. CGI of sleep [ Time Frame: three months, and two weeks, respectively ]
    clinical global impressions of sleep, comparing 3-month baseline with end of two weeks of treatment

  6. CGI of satisfaction with the cNEP device [ Time Frame: after two weeks of treatment ]
    clinical global impressions of the cNEP device

  7. Treatment-emergent adverse events [ Time Frame: two weeks ]
    tabulation of treatment-emergent adverse events



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • both parents ethnically Japanese, or one parent Japanese and the other east-Asian
  • PSG (polysomnogram) done within the previous 12 months that shows an AHI of 10-50/hr and <80% of apneas and hypopneas are obstructive
  • cNEP collar fits and is well-tolerated

Key exclusion Criteria:

  • BMI >34
  • abnormalities in neck structure
  • sleep disturbance other than obstructive sleep apnea
  • serious medical illness
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03375905


Locations
Layout table for location information
United States, Hawaii
The Sleep Lab
Kaneohe, Hawaii, United States, 96744
Sponsors and Collaborators
Sommetrics, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Jamil S Sulieman, MD The Sleep Lab, Kaneohe, HI
Layout table for additonal information
Responsible Party: Sommetrics, Inc.
ClinicalTrials.gov Identifier: NCT03375905    
Other Study ID Numbers: SOM-014
First Posted: December 18, 2017    Key Record Dates
Last Update Posted: September 19, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: Yes
Keywords provided by Sommetrics, Inc.:
ethnic Japanese
Additional relevant MeSH terms:
Layout table for MeSH terms
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases